Phase II Trial of Nab-Paclitaxel and Gemcitabine for First-Line Treatment of Patients With Cholangiocarcinoma
Clinical trial NCT02181634 · COMPLETED
Trial details
- NCT number
- NCT02181634
- Sponsor
- PrECOG, LLC.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-09
- Primary completion
- 2016-09-24
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.